Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bivalirudin Versus Enoxaparin for Anticoagulation in Critically Ill COVID-19 Patients: a Pilot Randomized Controlled Trial

NCT05334654 is registered in ClinicalTrials.gov with University Magna Graecia as lead sponsor.

NCT NCT05334654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05334654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bivalirudin Versus Enoxaparin for Anticoagulation in Critically Ill COVID-19 Patients: a Pilot Randomized Controlled Trial
Lead sponsor
University Magna Graecia
Phase
Not applicable
Overall status
Completed
Start date
April 20, 2022
Completion date
July 30, 2022
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory failure, anticoagulants, sars cov 2 infection